A call for change in anticancer drug evaluation

European Journal of Cancer Part A

Volumn 33, Issue SUPPL. 2, 1997, Pages S3-

  Cvitkovic, E ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

Methodology; Response rate; Therapeutic evaluation

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DESIGN; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL;

EID: 0030991813     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(96)00446-7     Document Type: Conference Paper

References (11)

1. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In MacLeod CM, ed. Chemotherapy of Cancer. New York, Columbia University Press, 1949, 191-205.
2. Tannock IF. Treating the patient, not just the cancer. N Engl J Med 1987, 317, 1534-1535.
3. Tannock IF, Boyer, M. When is a cancer treatment worthwhile? N Engl J Med 1990, 323, 989-990.
4. Zubrod CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960, 11, 7-31.
5. Hayward JL, Rubens RD, Carbone PP, Heuson J-C, Kumaoka S, Segaloff A. Assessment of response to therapy in advanced breast cancer. Br J Cancer 1977, 35, 292-298.
6. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981, 47, 207-214.
7. Gurland J, Johnson RO. How reliable are tumor measurements? JAMA 1965, 194, 973-978.
8. Lavin P, Flowerdew D. Studies in variation associated with the measurement of solid tumors. Cancer 1980, 46, 1286-1290.
9. Sobrero AF, Aschele C, Guglielmi AP, et al. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer. Clin Cancer Res 1995, 1, 955-960.
10. Graf W, Påhlman L, Bergström R, Glimelius B. The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br J Cancer 1994, 70, 559-563.
11. Pearl ML, Yashar CM, Johnston CM, Reynolds RK, Roberts JA. Exponential regression of CA 125 during salvage treatment of ovarian cancer with taxol. Gynecol Oncol 1994, 53, 339-343.